Institutional Ownership Gain Therapeutics, Inc. (GANX)
This table provides information about the institutional ownership of Gain Therapeutics, Inc. (GANX). We have compiled data on the 23 institutions that hold shares in the stock, with a total of 2.39 Million shares, which have been reported (via 13F filing form) to have a value of $3.89 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
David Einhorn
Greenlight Capital Inc | New York, Ny
|
Feb 14, 2024 Q4 2023 |
588,410
shares
|
$988,528
0.1% of portfolio
|
Q4 2023
Added 7.66%
|
|
|
Dme Capital Management, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
566,130
shares
|
$951,098
0.04% of portfolio
|
Q1 2024
New holding
|
|
|
Joel Greenblatt
Gotham Asset Management, LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
334,592
shares
|
$562,114
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
271,972
shares
|
$456,912
0.0% of portfolio
|
Q3 2024
Added 48.02%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
145,217
shares
|
$243,964
0.0% of portfolio
|
Q2 2024
Added 21.66%
|
|
|
Telemetry Investments, L.L.C.
New York, NY |
Feb 14, 2023 Q4 2022 |
123,000
shares
|
$206,640
0.61% of portfolio
|
Q4 2022
Reduced 18.0%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
84,620
shares
|
$142,161
0.0% of portfolio
|
Q2 2024
Added 12.23%
|
|
|
Jones Financial Companies Lllp
|
Nov 12, 2024 Q3 2024 |
53,500
shares
|
$89,880
0.0% of portfolio
|
Q3 2024
Added 664.29%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
53,264
shares
|
$89,483
0.0% of portfolio
|
Q3 2024
Reduced 55.13%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
44,944
shares
|
$75,505
0.0% of portfolio
|
Q2 2024
Reduced 3.32%
|
|
|
Prelude Capital Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
35,820
shares
|
$60,177
0.0% of portfolio
|
Q1 2024
Reduced 38.35%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
34,437
shares
|
$57,854
0.0% of portfolio
|
Q2 2024
Added 11.67%
|
|
|
Sandhill Capital Partners LLC
Buffalo, NY |
Nov 13, 2024 Q3 2024 |
15,400
shares
|
$25,872
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
8,455
shares
|
$14,204
0.0% of portfolio
|
Q3 2024
Reduced 25.98%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
4,842
shares
|
$8,134
0.0% of portfolio
|
Q3 2024
Added 180.05%
|
|
|
Simplex Trading, LLC
|
Nov 08, 2024 Q3 2024 |
4,801
shares
|
$8,065
0.0% of portfolio
|
Q3 2024
Reduced 47.0%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
4,800
shares
|
$8,064
0.0% of portfolio
|
Q3 2024
Added 45.45%
|
|
|
Creekmur Asset Management LLC
Morton, IL |
Oct 25, 2024 Q3 2024 |
4,440
shares
|
$7,459
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
3,584
shares
|
$6,021
0.0% of portfolio
|
Q3 2024
Added 2.4%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
2,650
shares
|
$4,452
0.0% of portfolio
|
Q2 2024
Reduced 29.45%
|
|
|
Group One Trading, L.P.
Chicago, IL |
Nov 14, 2024 Q3 2024 |
1,401
shares
|
$2,353
0.0% of portfolio
|
Q3 2024
Reduced 81.07%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|